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Abstract
Background: Several parameters are associated with high bone mineral density (BMD), such as overweight, black
background, intense physical activity (PA), greater calcium intake and some medications. The objectives are to
evaluate the prevalence and the main aspects associated with high BMD in healthy women.
Methods: After reviewing the database of approximately 21,500 BMD scans performed in the metropolitan area of
São Paulo, Brazil, from June 2005 to October 2010, high BMD (over 1400 g/cm2 at lumbar spine and/or above 1200
g/cm2 at femoral neck) was found in 421 exams. Exclusion criteria were age below 30 or above 60 years, black
ethnicity, pregnant or obese women, disease and/or medications known to interfere with bone metabolism. A
total of 40 women with high BMD were included and matched with 40 healthy women with normal BMD, paired
to weight, age, skin color and menopausal status. Medical history, food intake and PA were assessed through
validated questionnaires. Body composition was evaluated through a GE-Lunar DPX MD + bone densitometer.
Radiography of the thoracic and lumbar spine was carried out to exclude degenerative alterations or fractures.
Biochemical parameters included both lipid and hormonal profiles, along with mineral and bone metabolism.
Statistical analysis included parametric and nonparametric tests and linear regression models. P < 0.05 was
considered significant.
Results: The mean age was 50.9 (8.3) years. There was no significant difference between groups in relation to PA,
smoking, intake of calcium and vitamin D, as well as laboratory tests, except serum C-telopeptide of type I collagen
(s-CTX), which was lower in the high BMD group (p = 0.04). In the final model of multivariate regression, a lower
fat intake and body fatness as well a better profile of LDL-cholesterol predicted almost 35% of high BMD in
women. (adjusted R2 = 0.347; p < 0.001). In addition, greater amounts of lean mass and higher IGF-1 serum
concentrations played a protective role, regardless age and weight.
Conclusion: Our results demonstrate the potential deleterious effect of lipid metabolism-related components,
including fat intake and body fatness and worse lipid profile, on bone mass and metabolism in healthy women.
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Background
In recent years, the occurrence of high bone mineral
density (BMD) has been observed in some individuals
[1]. However, little is known about the prevalence, phy-
siopathogenic aspects involved, associated risk factors or
the clinical relevance of this entity in medical practice,
including the possibility to be a variant of normality or
be considered a disease itself, since it associates with
some morbidities.
So far, there is controversy about the definition of indi-
viduals with high BMD, since the World Health Organi-
zation [2] criteria for classification of osteopenia and
osteoporosis does not consider this condition. Thus, indi-
viduals with values above one standard deviation (SD) are
considered as normal, regardless of the absolute value or
the number of standard deviations above the unit.
Although there are few studies on this subject, most of
them point out to the role of anthropometric data (over-
weight and obesity) [3] and demographics (males and
black ethnicity) [4], as well as genetic factors (LRP5
mutations) [5], lifestyle habits (intense physical activity
[6], higher calcium intake above 1500 mg/day and food
or water with excess fluoride) [7,8], as the main factors
positively associated with high BMD. Some medications
such as statins [9] and thiazide diuretics [10] may also
have a protective effect. In addition, patients with breast
and endometrial cancer [11], type II diabetes mellitus
[12] and athletes have higher BMD than healthy indivi-
duals [13].
Thus, a better understanding of these aspects can help
to optimize the management of patients with osteoporo-
sis as well as minimize the burden of osteoporotic frac-
tures throughout the world.
The objective of this study was to identify the preva-
lence, as well as risk factors and protection associated
with high BMD in healthy women, through cross-sec-
tional study with control group.
Results
Clinical and nutritional data (mean ± SD) are listed in
Table 1. The groups were matched for age, weight, BMI,
smoking, fat mass and menopausal status. In both
groups, the prevalence of overweight was high, but with-
out significant difference between them. Nevertheless,
women with high BMD had higher FFM and ALM (p <
0.05). Seven healthy control women (17.5%) and three
(7.5%) of the high BMD group were classified as sarco-
penic (p = 0.31).
In the high BMD group, the only significant correla-
tions found were between femoral neck BMD and BF%
(r = -0.36; p = 0.02), BF (r = -0.45; p = 0.004) and RSMI
(r = 0.35; p = 0.02).
After the adjustment of food intake for energy, signifi-
cant difference was obtained between the groups
regarding the intake of protein and phosphorus, with
greater levels in women with high BMD (p < 0.05). The
mean daily consumption of lipids, carbohydrates and
vitamin D was similar in both groups. The mean intake
of macronutrients as well as phosphorus were within
the DRI values proposed by the Food and Nutrition
Board [14-16]. Conversely, the mean calcium and vita-
min D intake were below the proposed recommenda-
tions (Table 1).
While no statistically significant difference of meta-
bolic, hormonal and bone parameters was observed
Table 1 Anthropometric, clinical and nutritional data of
the population, according to BMD
HBMD
(N = 40)
Healthy controls
(N = 40)
p
Age (years) 50.9 (8.2) 51 (8.5) 0.989
Weight (kg) 64.3 (5.2) 61.7 (6.7) 0.052
Height (m) 1.58 (0.1) 1.57 (0.0) 0.241
BMI (kg/m2) 25.6 (2.4) 25.2 (2.6) 0.497
Age of menarche (years) 13.0 (2.4) 13.0 (1.4) 0.913
Parity 2.4 (1.4) 2.2 (1.3) 0.460
Smoking packets-year 16.7 (19.3) 26.2 (27.7) 0.290
TPA index (score) 7.6 (1.2) 7.9 (1.3) 0.412
Bone Mineral Density
Lumbar spine (g/cm2) 1.408 (0.1) 1.209 (0.1) < 0.001
T-score 1.9 (1.0) 0.2 (0.8) < 0.001
Z-score 2.5 (1.1) 0.9 (0.9) < 0.001
Femoral neck (g/cm2) 1.119 (0.1) 0.986 (0.08) < 0.001
T-score 0.9 (0.9) -0.2 (0.6) < 0.001
Z-score 1.7 (0.6) 0.7 (1.0) < 0.001
Total femoral (g/cm2) 1.166 (0.1) 1.043 (0.2) < 0.001
T-score 1.4 (1.0) 0.2 (0.7) < 0.001
Z-score 1.9 (1.1) 0.7 (0.7) < 0.001
Body Composition
FFM (kg) 36.4 (4.1) 34.4 (3.9) 0.029
ALM (kg) 16.1 (1.9) 15.0 (1.7) 0.007
RSMI (kg/m2) 6.3 (0.7) 6.1 (0.7) 0.278
Body fat (%) 39.4 (6.8) 40.5 (6.0) 0.433
Total body fat mass (kg) 24.0 (4.8) 23.6 (5.4) 0.740
Dietary Intake (day)
Energy (kcal) 1697.3 (460.5) 1749.3 (575.9) 0.653
Protein (g) 74.2 (10.9) 67.0 (11.3) 0.005
Fat (g) 57.6 (11.9) 58.8 (14.9) 0.700
Carbohidrate (g) 235.1 (30.7) 238.7 (36.9) 0.637
Calcium (mg) 836.4 (249.8) 754.7 (219.7) 0.124
Phosphorus (mg) 1178.9 (178.8) 1068.2 (153.9) 0.004
Vitamin D (μg) 1.9 (2.2) 2.0 (1.4) 0.944
BMI Body Mass Index, TFA Total Physical Activity, FFM Total Fat-Free Mass,
ALM Appendicular Lean Mass, RSMI Relative Skeletal Muscle Index, Nutrients
adjusted to energy. T- student Test
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between the groups, the serum concentration of total
cholesterol was above the recommended values and
more vitamin D insufficiency was found in the control
group (Table 2). In this group, only four women (10%)
reported 25-OH-D concentrations lower than 20 ng/mL.
In patients with high BMD, negative correlation was
verified between femoral neck BMD and total choles-
terol (r = -0.30; p = 0.01) and LDL-cholesterol (r =
-0.39; p = 0.01). On the other hand, serum IGF-1 corre-
lated positively with lumbar spine BMD (r = 0.36; p =
0.02). Similar correlation was also observed between 25-
OH-D and RSMI (r = 0.33; p = 0.04) and leptin and BF
(r = 0.44; p = 0.004). Bone resorption was lower in high
BMD women (p < 0.05) than in controls (Table 2).
In the final multiple linear regression model, IGF-1
was positively correlated with lumbar spine BMD in
women with high BMD after adjustments for age,
weight, BMI, menopause, smoking, lean mass and fat
and total energy of the diet. In contrast, LDL-cholesterol
and body fatness associated negatively while RSMI and
femoral neck BMD associated positively. Additionally,
higher fat intake as well as greater serum phosphorus
and iPTH had negative association with total body BMD
(Table 3).
Discussion
Our results show that the prevalence of women with
high BMD in the healthy general population is relatively
low (2%) and that the main positive aspects are indepen-
dently associated with IGF-1 and skeletal lean mass.
Conversely, aspects related to fats, such as higher body
fatness, increased plasmatic concentration of LDL-cho-
lesterol and fat intake, are associated negatively with the
BMD in these individuals.
To our knowledge, this is the first study that has iden-
tified the main risk factors and protection associated
with high BMD in healthy women from the general
population, including the three components of body
composition and nutritional aspects, as well as biochem-
ical, mineral and hormonal parameters.
It is important to note that there is still not a clear
definition of high BMD by the scientific community. In
the most recent (2007) official positions of the Interna-
tional Society for Clinical Densitometry (ISCD) [17],
there are no cut-off points (T- or Z-score) to classify
the patient with high BMD [18]. Some authors use Z-
score above 2.5 DP [19] and others consider the abso-
lute value of BMD (g/cm2) in its largest interquartile
range [1]. In this study, a T-score above + 2 SD, in the
absence of fractures or other osteosclerosing disorders,
was chosen for this classification. These values were
defined in accordance with the premise that T-score
values below - 2 SD are indicative of low BMD and
increased risk of fractures [17]. Thus, T-score values
above + 2 SD could be used to classify individuals with
high BMD.
IGF-1 works in both bone formation and resorption
[20] and thus plays a relevant role for the acquisition
and maintenance of bone mass. Looking at our data of
healthy adult women, there was significant association
with high BMD, especially in trabecular bone, explaining
Table 2 Metabolic, hormonal and biochemical parameters
of the metabolism bone and mineral of the population
study, according BMD
HBMD
(N = 40)
Healthy controls
(N = 40)
p
Glucose (mg/mL) 94.2 (20.0) 88.4 (17.4) 0.17
Uric acid (mg/dL) 4.8 (1.4) 4.5 (1.1) 0.40
Cholesterol total (mg/dL) 192.0 (45.3) 205.5 (38.6) 0.16
LDL-Cholesterol (mg/dL) 114.0 (32.4) 124.0 (33.2) 0.18
HDL-Cholesterol (mg/dL) 58.4 (13.2) 60.9 (9.5) 0.33
VLDL-Cholesterol (mg/dL) 22.3 (11.3) 21.8 (10.3) 0.86
Triglyceride (mg/dL) 111.9 (57.6) 109.9 (51.3) 0.82
Leptin (ng/mL) 0.4 (0.2) 0.4 (0.2) 0.78
IGF-1 (ng/mL) 115.7 (53.1) 134.5 (56.6) 0.13
Total testosterone (ng/dL) 22.8 (9.9) 26.9 (16.6) 0.59
Prolactin (ng/mL) 13.3 (15.6) 8.0 (4.6) 0.14
FSH (mUI/mL) 55.7 (50.9) 72.6 (51.5) 0.15
LH (mUI/mL) 18.2 (2.9) 20.2 (3.2) 0.09
Serum alkaline phosphatase (U/L) 108.9 (57.7) 113.3 (74.2) 0.77
Serum total calcium (mg/dL) 9.2 (0.4) 9.3 (0.4) 0.06
Serum ionic calcium (mmol/L) 1.2 (0.1) 1.2 (0.1) 0.66
Serum magnesium (mg/dL) 2.0 (0.2) 2.0 (0.2) 0.84
Serum phosphorus (mg/dL) 3.5 (0.5) 3.6 (0.5) 0.49
Serum CTX (ng/mL) 0.16 (0.2) 0.24 (0.3)* 0.04
Serum Vitamin D (ng/mL) 33.0 (15.7) 29.9 (9.5) 0.28
Serum PTH intact (pg/mL) 31.5 (14.9) 31.6 (15.4) 0.97
Urinary sodium (mEq/24h) 140.8 (68.2) 151.0 (58.9) 0.50
Urinary phosphorus (mg/24h) 381.7 (347.1) 432.4 (368.2) 0.56
Urinary calcium (mg/24h) 110.1 (84.7) 109.4 (103.4) 0.98
IGF-1 insulin-like growth factor, FSH follicle-stimulating hormone, LH
luteinizing hormone, CTX carboxy-terminal collagen crosslinks; Leptin, Prolactin,
CTX and Vitamin D were transformed in log for performed the statistical analysis;
Student’s t-test
Table 3 Final model of multivariable regression using
equations to estimate HBMD in women
Equations R R2 p
Spine BMD = 1.305+(0.361)IGF-1 0.361 0.108 0.022
Femur BMD = 1.096-0.272(TBFM)-
0.396(LDLC)+0.337(RSMI)
0.659 0.347 < 0.001
Total body BMD = 1.599-0.330(FI)-0.413(P)-
(0.298)PTH
0.649 0.367 < 0.001
IGF-1 insulin-like growth factor, TBFM total body fat mass, LDLC, LDL-
cholesterol, RSMI, relative skeletal muscle index, BMD, body mineral density, FI
fat intake, P serum phosphorus, iPTH intact serum parathyroid hormone;
Models adjusted for age, weight, height, BMI, smoking, lean mass, fat mass,
energy intake and menopause
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nearly 11% of the bone density variation in these indivi-
duals. Other authors have found similar results [21-23].
Although there is vast positive evidence of IGF on
bone mass, its function should be better explored.
Recently, Cohen et al. showed osteoblasts seem to be
resistant to the IGF-1 effect in women with osteoporo-
sis. Thus, it would not have a positive role and should
be evaluated with caution [24]. Furthermore, Clemens &
Karsenty, underscore osteocalcin as a regulator of glu-
cose metabolism by means of insulin receptors present
in osteoblasts, acting both on systemic glucose homeos-
tasis and BMD increment [25].
Lean mass is the main component of body composi-
tion associated with BMD [26-29], in which mechanical
stress [30] and mechanosensory signaling, promoted by
osteocytes, are the most studied determinants [31].
These aspects have been partially confirmed by our
results since physical activity, per se, was unable to
explain high BMD in healthy women.
Most likely, the women with high BMD evaluated in
our study had lower bone resorption rate, as suggested
by the lower values of CTX when compared to healthy
controls. In view of the negative correlation between
this bone turnover marker and the RSMI (r = -0.31; p =
0.05), we suggest that the trophic role of muscle mass
(pro formation), associated with lower bone resorption,
resulted in a positive net effect on BMD. One of the
possibilities to explain lower bone resorption in women
with high BMD may be lower serum FSH- and LH-
plasma concentrations (p = 0.09), which inherently can
play a negative role on bone tissue [32,33].
Alternatively, there are conflicting studies on the role
of fat mass on BMD [34,35], since body weight tradi-
tionally has a positive role on bone mass, especially with
greater cortical and periosteal remodeling [35]. In our
case, fat mass, including percentage and absolute values,
played a negative role on femoral neck BMD, indepen-
dent of body weight, hormonal variables (aromatization
of estrone to estradiol), and adiposity type (gynecoid vs.
android).
The physiopathogenic mechanisms involved with the
deleterious role of body fatness on bone tissue are not
fully known, but some authors believe that protective
bone strength is most associated with dynamic loads,
those found with lean and muscular mass, than with sta-
tic, observed with fat mass [36]. Moreover, the proin-
flammatory state observed in individuals with obesity or
with greater adiposity may be related to increased bone
resorption and thus greater injury to bone health, intro-
ducing the new concept of lipotoxicity [37].
It is important to emphasize that, according to our
data, there was positive correlation between BF and
serum leptin concentrations, suggesting greater periph-
eral resistance to leptin and therefore to insulin.
Recently, leptin has been pointed out as an important
regulator of osteoclast differentiation, since it controls
the expression of RANKL (receptor activator of nuclear
factor kappa-B ligand) and CART (cocaine and amphe-
tamine regulated transcript) [38].
Worse lipid profile, defined by LDL cholesterol, was
another aspect negatively associated with femoral neck
BMD in women with high BMD, emphasizing once
again the participation of lipid metabolism on bone tis-
sue [35]. Lipoprotein lipid oxidation is able to stimulate
osteoclastogenesis [39], as well as the greater intake of
fats, via RANKL expression on activated T lymphocytes
[40]. Moreover, this oxidation may have a negative
action on osteoblast differentiation and bone formation
[41]. Recently, some authors have shown greater bone
loss [42] and increase in resorption bone markers in
patients with hypercholesterolemia [43].
Although the incidence of dyslipidemia in patients
with osteoporosis is still not known, the atherogenic
lipid profile is known to be significantly associated with
lower bone density in postmenopausal women [44].
However, the use of statins does not seem to play a ben-
eficial role on bone health [45].
Likewise, the daily intake of lipids was also a factor
negatively associated with BMD, as previously reported
by other authors [46]. The ingestion of large amounts of
fat can negatively affect the absorption of calcium, pros-
taglandin synthesis and osteoclastogenesis. It also
increases the oxidation of lipids [47]. In addition, the
ingestion of large amounts of fat is related to the
increased expression of adipocyte differentiation factors,
in particular to PPAR-g (peroxisome proliferator-acti-
vated receptor gamma) [48]. According to data from the
Framingham Osteoporosis Study, high fat consumption
can be harmful to bone mass, particularly in individuals
with greater allelic variation in PPAR-g [48]. In our
study, no gene polymorphisms were evaluated. It is
worth mentioning that the exclusion of obese women
reinforces our findings, since, in all likelihood, they con-
sumed even more fat. Thus, lipid consumption above
DRI recommendations is able to negatively affect BMD.
Traditionally, higher concentrations of iPTH and
phosphorus are associated with worse bone health, as
observed in patients with chronic renal insufficiency.
Our results show that this combination is associated
negatively with BMD in patients with high BMD.
Surprisingly, no significant difference was observed in
mean plasma concentrations of vitamin D between the
groups. Accordingly, women had high BMD indepen-
dent of vitamin D, while on the other hand there was
positive interaction between vitamin D, lean mass and
higher femoral neck BMD. The role of vitamin D recep-
tor (VDR) in muscle cells [49] could explain these find-
ings. Unfortunately, falls, muscle strength and physical
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incapacity were not objectives of this study and further
research is needed to better understand the interaction
between these aspects.
Additionally, women with high BMD had higher
intake of protein and phosphorus, after adjustments for
energy. However, when adjusted for protein intake,
there was no significant difference in the daily intake of
phosphorus (1144 .1 ± 140.3 vs. 1103.6 ± 123.8 mg, p =
0.17) between the high BMD and control groups,
respectively. Several epidemiological observations on
protein intake confirm our results [50], although some
have shown a negative role [51]. When observing the
beneficial role of protein intake, it is important to note
that the effect of the protein-induced acid load does not
promote bone loss or urinary calcium [52]. In addition,
protein intake is able to increase IGF-1 values by almost
30% [53] and thus provide beneficial effect on bone
metabolism. The combination of these two latter aspects
was observed in our study.
Conversely, when evaluating protein intake (g)
adjusted for body weight (g/kg), there was no significant
difference between groups (1.2 g/kg for high BMD vs.
1.1 g/kg in controls, p = 0.2), although both were above
the recommendation for healthy individuals (0.8 g/kg).
The limitations of this study include the lack of eva-
luation of genetic markers, the lack of measurement of
muscle strength and variables that quantify the state of
oxidative stress, as well as the amount of fluoride in
water or in food ingested and the type and the quantifi-
cation of visceral fat.
The strengths of this study included the careful selection
of the sampling procedures, excluding the risk factors tra-
ditionally associated with high BMD such as black ethni-
city, obese individuals, athletes and patients infected by
hepatitis C virus (HCV) or with degenerative alterations of
the lumbar spine or hip. Moreover, results were strength-
ened with the inclusion of a control group matched for
age, weight, fat mass, ethnicity, physical activity and smok-
ing, which reduces various biases and confounding factors.
This study expands upon the scientific understanding
of bone and mineral metabolism, since it includes new
aspects of practical interest, such as body adiposity, lipid
profile and fat intake, and the non-pharmacological
handling of patients with bone fragility. Thus, beyond
adapting the intake of calcium and vitamin D and sti-
mulating resistance exercises for an individual with
osteoporosis, the physician and nutritionist should also
guide the lower intake of fats, encourage aerobic activ-
ities and improve the lipid profile of these individuals.
Conclusion
Thus, our results show that the main protection factors
associated with high BMD in healthy women are IGF-1
plasmatic concentration, skeletal lean mass and intake
of protein. On the other hand, body fatness, worse lipid
profile and fat intake played a negative role.
Methods
Study design, sampling and patient selection
After reviewing the database of approximately 21,500
BMD scans performed in healthy women for any reason,
from June 2005 to October 2010, were found 421 exams
(1.96%) with high BMD. This information has been ori-
ginated from the São Paulo metropolitan area, Brazil,
including primary, secondary and tertiary hospitals as
well as data from general practitioners.
Through convenience sampling and consecutively, exams
with BMD values above 1400 g/cm2 or T-score greater
than + 2 SD at lumbar spine and/or above 1200 g/cm2 or
T-score greater than + 2 SD at femoral neck were eligible
to this study. Furthermore, none of these sites could have
osteopenia or osteoporosis [2] or previous fracture.
The control group included healthy women matched
for age, weight and ethnicity. Besides, they had BMD
values lower than 1400 g/cm2 (T-score less than 1.99
DP) at lumbar spine and/or under 1200 g/cm2 (T-score
less than 1.99 DP) at femoral neck. Similarly, none of
the sites could have osteopenia or osteoporosis [2].
Women aged below 30 and above 65 years, black peo-
ple, pregnant and those with BMI higher than 29.9 kg/
m2 were excluded. Moreover, the presence of diseases
associated with any nutritional imbalance or osteometa-
bolic conditions, including renal, infectious, neoplastic,
digestive, endocrinologic, rheumatic and cardiovascular
diseases were not included. History of alcoholic con-
sumption [54], dyslipidemia, chronic hepatitis C, hor-
mone treatment and individuals using statins or thiazide
diuretics also were not eligible for the study.
Of 421 women, 381 (90.5%) were excluded for not
meeting the eligibility criteria, particularly obesity and
black ethnicity. Thus, 40 (9.5%) women constituted the
study group.
The study protocol was examined and approved by
the Research Ethics Committee of the University of São
Paulo (USP) (number: 0170/09) and Universidade Fed-
eral de São Paulo (Unifesp/EPM) (number: 0229/04) and
the participants who agreed to participate in the study
gave written informed consent.
Collection of clinical information
Standardized questionnaires were used to verify the
demographic characteristics and medical history. Meno-
pause was defined as more than 12 months since the
last menstrual period [55].
Evaluation of food intake
Food intake was measured through a Food Frequency
Questionnaire (FFQ), consisting of 62 food items and
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validated in Brazil [56]. The FFQ was administered by a
trained nutritionist and the information provided
reflected the pattern of food intake for the last six
months. Portion size was evaluated with the aid of a
food portion photo set.
Dietsys software, version 4.0 (National Cancer Insti-
tute, Bethesda, MD), was used to calculate the daily
nutritional intake of total energy (kcal/day), macronutri-
ents and some micronutrients, including calcium, phos-
phorus and vitamin D. All nutrients were adjusted for
energy. Phosphorus was also adjusted to protein intake
according to the method proposed by Willett & Stamp-
fer [57] and compared with the Dietary Reference
Intakes (DRIs) recommendation from Food and Nutri-
tion Board [14-16].
Evaluation of physical activity
Physical activity (PA) was assessed through the Baecke
Questionnaire of Habitual Physical Activity [58]. This
tool evaluates three PA’s main components: work, sport
and leisure. All the answers, with the exception of the
occupation activity and the type of sport, were precoded
on a scale of 5 points, with descriptors that range from
never (1) to very often (5). The level of occupational
activity was classified as low (1), medium (3) or high (5).
The score of sport activities was calculated by the equa-
tion: [intensity code × duration code × year proportion
code] × 1.25. If there was more than one sport prac-
ticed, the values were added. As a result, each compo-
nent of PA can receive a maximum of five points, with
a maximum score of 15. Each index was rounded to the
nearest tenth of the unit or point.
Anthropometry
All individuals were measured and weighed on a stan-
dard balance beam scale (Filizola®), calibrated periodi-
cally, wearing light clothes and without shoes. Weight
was measured to the nearest 100 g. Standing height was
measured with the aid of a stadiometer (Filizola®) by a
trained individual. Body mass index (BMI) was calcu-
lated by the ratio between weight (kg) and height, in
meters squared (kg/m2).
Assessment of body composition and bone mineral
density measurements
BMD assessment was performed on the lumbar spine (L1-
L4) and femoral neck (g/cm2) by using dual energy X-ray
absorptiometry (DXA), DPX MD + densitometer (GE-
Lunar Radiation Corporation, Madison, WI, USA). A well-
trained technician followed a standard protocol. Quality
control was done daily and phantom cross-calibration
three times per week. For premenopausal women, Z-score
was used in compliance with International Society of
Clinical Densitometry (ISCD) recommendations [21] and
supported by the Brazilian Society of Clinical Densitome-
try (SBDens), a national regulatory agency [59].
Body composition was also measured by DXA. Total
body fat mass was evaluated in absolute values as body
fat (kg) and percentage (BF%). Lean mass was defined as
fat free mass (FFM), with special emphasis to appendi-
cular lean mass (ALM) and the relative skeletal muscle
index (RSMI). For women aged over 50 years, sarcope-
nia was defined according to the classification of Baum-
gartner [60], in which RSMI values below two standard
deviations relative to young healthy population or less
than 5.45 kg/m2, for women; indicative of that condi-
tion. For younger women, the criterion was not used.
RSMI is the ratio of appendicular lean mass (kg) and
height squared (m2).
The coefficient of variation was 1.5% for the lumbar
spine and total body and 2% for the femoral neck.
Radiographic evaluation
Radiographic evaluation of dorsal and lumbar spine in
anteroposterior and lateral positions was performed by a
rheumatologist blinded for clinical data and specific pro-
cedures of the protocol data in order to exclude vertebral
degenerative processes, as well as other causes of high
BMD, including bone metastases, Paget’s disease, fracture
or congenital deformities (Schmorl’s nodes, severe scolio-
sis). The image acquisition protocol followed the recom-
mendation of 120 cm for tube film distance and X-ray
beams centered in T8 and L3, respectively.
Laboratory and biochemical analysis
All the blood samples were collected in the morning
after twelve hours of fasting.
Metabolic and hormonal parameters included glucose
and uric acid, both evaluated by calorimetry; total cho-
lesterol, fractions and triglycerides by the Trinder
method; insulin growth factor-1 (IGF-1) by chemilumi-
nescence, leptin by ELISA (IBL International) and total
testosterone by RIA. Prolactin, follicle-stimulating hor-
mone (FSH) and luteinizing hormone (LH) were mea-
sured by fluorometric method.
Bone and mineral metabolism were also measured.
Bone formation was evaluated by alkaline phosphatase
(ALP) activity through enzymatic-kinetic method. Bone
resorption was assessed by serum C-terminal fragment of
type-I collagen (CTX), through chemiluminescence.
Serum total calcium, ionized calcium and magnesium
were measured by colorimetric assay and serum phos-
phorus by UV mobility. Intact parathyroid hormone
(iPTH) and 25-hydroxivitamin D (25-OH-D) were evalu-
ated by electrochemiluminescence. Additionally, 24-hour
urine was collected for measuring urinary calcium by col-
orimetric assay, as well as the fraction of sodium excre-
tion (potentiometry) and phosphorus (UV mobility).
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The classification of vitamin D sufficiency adopted was
proposed by Dawson-Hughes [61].
Statistical analysis
The results were analyzed as mean ± SD. The Kolmo-
gorov-Smirnov test was used to verify the normal distri-
bution of variables. Data with non-normal distribution
were transformed into logarithm. Mean differences
between groups were assessed by Student’s t-test. Cate-
gorical variables were analyzed by chi-square test of
association. The correlation between variables was eval-
uated by parametric tests and Pearson correlation.
Multiple linear regression models were used to iden-
tify factors associated with high BMD, used as depen-
dent variable. Clinical characteristics, food intake data,
physical activity score, body composition measurements
and concentrations of biochemical parameters were con-
sidered as independent. P-values of < 0.05 were consid-
ered significant. All analyses were performed with the
aid of Statistical Package for the Social Sciences, version
16.5 for Windows (SPSS Inc., Chicago, IL).
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